138 related articles for article (PubMed ID: 16039404)
21. [Sexual dysfunction in the menopause. Incidence, pharmacological treatment and side effects].
Gregersen N; Hilmand CB; Jensen PT; Giraldi AG
Ugeskr Laeger; 2006 Feb; 168(6):559-63. PubMed ID: 16476214
[TBL] [Abstract][Full Text] [Related]
22. Tibolone.
Reynir Tomas G
Acta Obstet Gynecol Scand; 2004 Jun; 83(6):606. PubMed ID: 15144349
[No Abstract] [Full Text] [Related]
23. Endometrial cancer and hormone-replacement therapy.
Bjarnason NH
Lancet; 2005 Jul 16-22; 366(9481):200-1. PubMed ID: 16023503
[No Abstract] [Full Text] [Related]
24. Breast cancer and hormone-replacement therapy: the Million Women Study.
Bundred NJ; Morris J
Lancet; 2003 Oct; 362(9392):1329; author reply 1330-1. PubMed ID: 14575987
[No Abstract] [Full Text] [Related]
25. Hormone replacement therapy use and variations in the risk of breast cancer.
Opatrny L; Dell'Aniello S; Assouline S; Suissa S
BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
[TBL] [Abstract][Full Text] [Related]
26. Bleeding with menopausal hormone therapy.
Hickey M; Agarwal S
Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):141-9. PubMed ID: 18977184
[TBL] [Abstract][Full Text] [Related]
27. Tibolone is not used as a first-line therapy: implications for the Million Women Study analysis.
Seeley T
J Br Menopause Soc; 2006 Jun; 12(2):81. PubMed ID: 16776860
[No Abstract] [Full Text] [Related]
28. Chronic administration of tibolone modulates anxiety-like behavior and enhances cognitive performance in ovariectomized rats.
Espinosa-Raya J; Neri-Gómez T; Orozco-Suárez S; Campos MG; Guerra-Araiza C
Horm Behav; 2012 Jan; 61(1):76-83. PubMed ID: 22067260
[TBL] [Abstract][Full Text] [Related]
29. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
[TBL] [Abstract][Full Text] [Related]
30. What influence does hormone replacement therapy have on endometrial cancer risk?
Barakat RR
Nat Clin Pract Oncol; 2005 Nov; 2(11):546-7. PubMed ID: 16270092
[No Abstract] [Full Text] [Related]
31. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A
Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769
[TBL] [Abstract][Full Text] [Related]
32. What have we really learned from 'LIBERATE' trial?
Dimitrakakis C; Tsigginou A; Keramopoulos D; Antsaklis A
Maturitas; 2010 May; 66(1):99-100. PubMed ID: 20236777
[TBL] [Abstract][Full Text] [Related]
33. Relationship between tamoxifen use and high risk endometrial cancer histologic types.
Bland AE; Calingaert B; Secord AA; Lee PS; Valea FA; Berchuck A; Soper JT; Havrilesky L
Gynecol Oncol; 2009 Jan; 112(1):150-4. PubMed ID: 18937966
[TBL] [Abstract][Full Text] [Related]
34. Tibolone and risk of gynecological hormone sensitive cancer.
Løkkegaard ECL; Mørch LS
Int J Cancer; 2018 Jun; 142(12):2435-2440. PubMed ID: 29349823
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.
Shang Y
Nat Rev Cancer; 2006 May; 6(5):360-8. PubMed ID: 16633364
[TBL] [Abstract][Full Text] [Related]
36. Endometrial polyps in pre-and postmenopausal women: factors associated with malignancy.
Cohen I
Maturitas; 2008 Jan; 59(1):99-100. PubMed ID: 18162338
[No Abstract] [Full Text] [Related]
37. Postmenopausal osteoporosis: therapeutic options.
Genazzani AR; Gambacciani M; Schneider HP; Christiansen C;
Climacteric; 2005 Jun; 8(2):99-109. PubMed ID: 16096166
[No Abstract] [Full Text] [Related]
38. Risk factors for the incidence of endometrial cancer according to the aggressiveness of disease.
Weiss JM; Saltzman BS; Doherty JA; Voigt LF; Chen C; Beresford SA; Hill DA; Weiss NS
Am J Epidemiol; 2006 Jul; 164(1):56-62. PubMed ID: 16675538
[TBL] [Abstract][Full Text] [Related]
39. Does tibolone exacerbate atherosclerosis?
Clarkson TB
Eur Heart J; 2006 Mar; 27(6):635-7. PubMed ID: 16415302
[No Abstract] [Full Text] [Related]
40. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
Chang SC; Lacey JV; Brinton LA; Hartge P; Adams K; Mouw T; Carroll L; Hollenbeck A; Schatzkin A; Leitzmann MF
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):723-30. PubMed ID: 17416763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
